To include your compound in the COVID-19 Resource Center, submit it here.

Chelsea gains as regulatory cloud lifts for Northera

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) gained $0.88 (22%) to $4.86 on Monday after providing additional clarity on its regulatory plans

Read the full 206 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE